Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Ligand Pharmaceuticals Incorporated (LGND)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
150.72-6.20 (-3.95%)
At close: 04:00PM EST
150.72 0.00 (0.00%)
After hours: 06:03PM EST
Advertisement
Advertisement
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Total Revenue
274,650
186,419
120,282
251,453
141,102
Cost of Revenue
61,931
30,419
11,347
6,337
5,366
Gross Profit
212,719
156,000
108,935
245,116
135,736
Operating Expense
152,462
147,269
114,656
81,389
67,660
Operating Income
60,257
8,731
-5,721
163,727
68,076
Net Non Operating Interest Income Expense
-20,458
-19,342
-7,315
-34,277
-11,400
Other Income Expense
17,895
73
809,675
43,880
555
Pretax Income
57,694
-10,538
796,639
173,330
57,231
Tax Provision
-10,621
-7,553
167,337
30,009
44,675
Net Income Common Stockholders
68,315
-2,985
629,302
143,321
12,556
Diluted NI Available to Com Stockholders
68,315
-2,985
629,302
143,321
12,556
Basic EPS
-
-0.18
33.13
6.77
0.60
Diluted EPS
-
-0.18
31.85
5.96
0.53
Basic Average Shares
-
16,185
18,995
21,160
21,032
Diluted Average Shares
-
16,185
19,757
24,067
23,481
Total Operating Income as Reported
77,371
25,845
807,076
163,727
68,076
Total Expenses
214,393
177,688
126,003
87,726
73,026
Net Income from Continuing & Discontinued Operation
68,315
-2,985
629,302
143,321
12,556
Normalized Income
49,730
-3,117
-12,808
143,321
14,104
Interest Income
1,086
8,078
28,430
13,999
-
Interest Expense
21,544
27,420
35,745
48,276
-
Net Interest Income
-20,458
-19,342
-7,315
-34,277
-11,400
EBIT
79,238
16,882
832,384
221,606
68,076
EBITDA
130,052
-
-
-
-
Reconciled Cost of Revenue
58,665
25,895
11,347
7,411
5,772
Reconciled Depreciation
50,814
27,966
43,731
14,718
11,714
Net Income from Continuing Operation Net Minority Interest
68,315
-2,985
629,302
143,321
12,556
Total Unusual Items Excluding Goodwill
25,459
181
812,797
-
-2,580
Total Unusual Items
25,459
181
812,797
-
-2,580
Normalized EBITDA
104,593
44,667
63,318
237,398
82,776
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
6,874
48.87
170,687
0
-1,032
Advertisement
Advertisement